… Our results also showed that in the group of untreated patients with lung cancer, following
survival analysis results and survival rates, only two distinctive staging groups could be …

… survival. Here we present the development of an online tool suitable for the real-time
meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival…

Purpose: Somatic mutations of the epidermal growth factor receptor (EGFR) gene are associated
with an increased response to gefitinib in patients with non–small cell lung cancer. We …

… The final analysis of the PROFILE 1014 study provides a new benchmark for OS in patients
… –small-cell lung cancer and highlights the benefit of crizotinib for prolonging survival in this …

… nonsmall cell lung cancer (NSCLC), we sought to determine the long-term survival impact of
… be associated with both operative morbidity and cancer survival, it was our aim to separate …

… and Taxol in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 13:351, 1994 …
lung cancer cell lines to paclitaxel increases the cytotoxicity. Proc Int Assoc Study Lung Cancer …

… For the purposes of this series, we will focus on the time to first relapse (including death
from lung cancer). Table 1 gives the time of the earliest 15 and latest five relapses for each …

… analysis summarized above was March 2004. In this paper, we describe an updated survival
analysis in … We also present the 3-year survival rates in the intent-to-treat population and …

Purpose Adjuvant cisplatin-based chemotherapy (ACT) is now an accepted standard for
completely resected stage II and III A non–small-cell lung cancer (NSCLC). Long-term follow-up …

… Lung cancer is the most common cancer worldwide, in terms of both incidence and … to lung
cancer. The highest rates are in Europe and North America (Ferlay et al, 2010). Lung cancer …